Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Tissue Array Analysis × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Ipilimumab 80 pembrolizumab 78 Nivolumab 71 Cyclophosphamide 61 fludarabine phosphate 48 aldesleukin 45 Interleukin-2 33 Vemurafenib 29 Dacarbazine 29 fludarabine 28 trametinib 25 dabrafenib 24 Temozolomide 21 Aminolevulinic Acid 18 Whole-Body Irradiation 17 Radiosurgery 17 Bevacizumab 17 Carboplatin 16 Radiotherapy 15 3-ingenyl angelate 15 Peripheral Blood Stem Cell Transplantation 14 Paclitaxel 13 Mycophenolic Acid 13 HhAntag691 13 Tacrolimus 12 Introns 12 Interferon alpha-2 12 Cyclosporine 12 CTLA-4 Antigen 12 Antilymphocyte Serum 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02236546 2017-04-13

FDG-PET in Advanced Melanoma

Vanderbilt-Ingram Cancer Center

Phase NA Terminated

3 enrolled 4 charts

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡